Bayer Launches Disease Resistant Rice
May 16, 2008| |
Bayer CropScience has announced the launch of Arize Dhani, a bacterial leaf blight (BLB) disease-resistant hybrid rice variety in India. Bayer claims that, in addition to providing broad protection against BLB, the new rice hybrid can increase yield by 20 to 30 percent compared to ordinary varieties. The company now markets seven rice varieties in India.
Bacterial blight, caused by Xanthomonas oryzae, is one of the most common diseases affecting rice worldwide. Xanthomonas strains in tropical areas are more virulent than that of in temperate regions. In India, BLB affects 6-7 million hectares annually causing an estimated yield reduction of up to 60 percent. The country is the second largest rice producer after China, growing more than 128 million tons of the staple.
The press release is available at http://www.bayercropscience.com/bayer/cropscience/cscms.nsf/id/20080514_EN?open&ccm=400
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- FAO Sees Strong Signs of Record Rice Production
- UN Conference Discusses Liability Rules and Redress
- New Ideas to Boost World Tea Market
- Uganda Puts Up Biotech Center for Cassava
- ARS Releases Nematode, Virus Resistant Peanut Variety
- GE Approaches to Improve Nitrogen Use Efficiency
- DuPont and Genencor Form Cellulosic Ethanol Venture
- Taiwan Implements Stacks Registration
- ABARE Report : Australia to Benefit from GM Crops
- Pakistan Environment Minister Calls for GMOs in Agriculture
- Agricultural Scientists in Pakistan Urged to Develop Biotech Varieties
- Bayer Launches Disease Resistant Rice
- ICRISAT: Sweet Sorghum Could be the Miracle Biofuel Crop
- DEFRA Approves GM Potato Trial
- PRRI Open Letter to EC Members
- German Ag-Industries Say EU Biotech Policy Affecting Supply Problem
- Plant Bioscience Enters Licensing Agreement
-
Research Highlights
- Starch Degrading Enzyme from GM Potatoes
- GM Tobacco Expressing Cervical Cancer Vaccine
- Brassinosteroids and Water Stress Response
-
Resources
- CropLife International Online Database on Agri-biotech Benefits
-
Read the latest: - Biotech Updates (January 22, 2025)
- Gene Editing Supplement (January 15, 2025)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet